Summary & Overview
CPT 51784: Electromyography Studies of Anal or Urethral Sphincter
CPT code 51784 represents electromyography studies (EMG) of the anal or urethral sphincter, performed using non-needle techniques. This procedure is a key component of urodynamic testing, providing valuable information about the neuromuscular function of sphincter muscles. It is commonly performed in office settings and is relevant for patients with neurological or urological disorders affecting continence.
Major national payers, including Aetna, Blue Cross Blue Shield, Cigna Health, Medicare, and UnitedHealthcare, recognize and reimburse for this procedure. The publication offers a comprehensive overview of payer coverage, clinical indications, and related coding practices. Readers will gain insights into current policy updates, coding benchmarks, and the clinical context for the use of 51784.
The article also highlights associated modifiers, relevant provider taxonomies, and ICD-10 diagnoses commonly linked to this procedure. Additionally, it provides comparisons to related CPT codes, helping readers understand the distinctions between various urodynamic and EMG services. This summary serves as a resource for understanding the national landscape of coverage and coding for EMG studies of the anal or urethral sphincter.
CPT Code Overview
CPT code 51784 is used to report electromyography studies (EMG) of the anal or urethral sphincter, performed using techniques other than needle insertion. This procedure is classified under Urodynamic Procedures on the Bladder and is typically conducted in an office setting (Place of Service 11). EMG studies of the sphincter muscles are important for evaluating neuromuscular function related to urinary and fecal continence, aiding in the diagnosis and management of various neurological and urological conditions.
Clinical & Coding Specifications
Clinical Context
A typical patient scenario involves an individual presenting with symptoms of neurogenic bladder or bowel dysfunction, often due to underlying neurological conditions such as multiple sclerosis, paraplegia, or hemiplegia. The patient may experience urinary or fecal incontinence, retention, or difficulty with voiding. During the clinical workflow, the provider evaluates the patient’s history and symptoms, then performs electromyography studies of the anal or urethral sphincter using a non-needle technique to assess muscle function and nerve integrity. This procedure is commonly performed in an office setting by specialists in urology, colon & rectal surgery, or proctology.
Coding Specifications
-
Modifier
26: Used to indicate the professional component of the service, when only the physician’s interpretation and report are billed. -
Modifier
TC: Used to indicate the technical component, when only the equipment, supplies, and technical staff are billed.
| Taxonomy Code | Specialty |
|---|---|
208800000X | Urology Physician |
208C00000X | Colon & Rectal Surgery Physician |
208D00000X | Proctology Physician |
Related Diagnoses
-
G04.1: Tropical spastic paraplegia- Relevant for patients with spastic paralysis affecting sphincter control.
-
G35: Multiple sclerosis- Often associated with neurogenic bladder or bowel dysfunction requiring EMG studies.
-
G81.01: Flaccid hemiplegia affecting right dominant side- Indicates loss of muscle tone and control, potentially impacting sphincter function.
-
G81.02: Flaccid hemiplegia affecting left dominant side- Similar clinical relevance as above, affecting sphincter control.
-
G81.03: Flaccid hemiplegia affecting right nondominant side- May result in impaired sphincter function.
-
G81.04: Flaccid hemiplegia affecting left nondominant side- Associated with sphincter dysfunction.
-
G81.11: Spastic hemiplegia affecting right dominant side- Spasticity can affect voluntary sphincter control.
-
G81.12: Spastic hemiplegia affecting left dominant side- Relevant for sphincter EMG assessment.
-
G81.13: Spastic hemiplegia affecting right nondominant side- May impact sphincter function.
-
G81.14: Spastic hemiplegia affecting left nondominant side- Indicates possible sphincter dysfunction.
-
G81.91: Hemiplegia, unspecified affecting right dominant side- Used when hemiplegia is present but not further specified.
-
G81.92: Hemiplegia, unspecified affecting left dominant side- Indicates potential sphincter involvement.
-
G81.93: Hemiplegia, unspecified affecting right nondominant side- May require EMG studies for sphincter assessment.
-
G81.94: Hemiplegia, unspecified affecting left nondominant side- Relevant for evaluating sphincter function.
-
G82.20: Paraplegia, unspecified- Paraplegia often leads to neurogenic sphincter dysfunction.
-
G82.21: Paraplegia, complete- Complete loss of motor function may necessitate EMG studies.
-
G82.22: Paraplegia, incomplete- Partial loss of function, EMG can help assess sphincter involvement.
-
G82.51: Quadriplegia, C1-C4 complete- Severe neurological impairment affecting sphincter control.
-
G82.52: Quadriplegia, C1-C4 incomplete- Partial impairment, EMG studies may be indicated.
-
G82.53: Quadriplegia, C5-C7 complete- Complete loss of function, relevant for sphincter EMG.
-
G82.54: Quadriplegia, C5-C7 incomplete- Partial loss, EMG can assess sphincter function.
-
G83.0: Diplegia of upper limbs- May be associated with neurological conditions affecting sphincter control.
-
G83.11: Monoplegia of lower limb affecting right dominant side- Indicates possible involvement of sphincter muscles due to neurological impairment.
Related CPT Codes
-
51785: Needle electromyography studies (EMG) of anal or urethral sphincter, any technique- Used as an alternative to
51784when a needle technique is required for EMG studies.
- Used as an alternative to
-
51741: Complex uroflowmetry (not needle)- Often performed in conjunction with
51784to assess urinary flow and sphincter function.
- Often performed in conjunction with
-
51728: Complex cystometrogram with voiding pressure studies- May be used alongside
51784to evaluate bladder and sphincter function during urodynamic testing.
- May be used alongside
-
90911: Biofeedback training, perineal muscles, anorectal or urethral sphincter, including EMG and/or manometry- Can be used in follow-up or as a therapeutic intervention after EMG studies to improve sphincter control.
These codes are commonly used together in comprehensive urodynamic evaluations or as alternatives depending on the technique and clinical need.
National Reimbursement Benchmarks
National mean rates for CPT code 51784 show a significant gap between Medicare and commercial payers. Medicare's mean rate is $45.77, while the BUCA (average commercial) mean rate is $91.25, nearly double the Medicare rate. Among individual commercial payers, Cigna has the highest mean rate at $117.46, and Aetna the lowest at $79.86.
Rate dispersion, measured by the difference between the 75th and 25th percentiles, varies across payers. Medicare has the tightest range at $32.50, indicating less variability in reimbursement. Cigna exhibits the widest dispersion at $92.56, reflecting greater variability in rates paid. Other commercial payers such as UnitedHealth Group and Blue Cross Blue Shield have moderate ranges of $71.04 and $49.07, respectively.
The table and chart below present the full breakdown of national benchmarks for each payer, including mean rates and percentile values.
State Benchmarks
State: AK1 / 50
Alaska Benchmarks
Alaska exhibits a wide spread in reimbursement rates for CPT code 51784, with the commercial payers showing substantial differences between the 25th and 75th percentiles. For example, Cigna's rate spread is $86.33 ($158.33 minus $72.00), while Blue Cross Blue Shield's spread is $35.37 ($151.25 minus $115.88). This indicates significant variability in negotiated rates across payers within the state. Medicare's rates are notably lower, with a spread of $32.00 ($63.00 minus $31.00), reflecting the more standardized approach of federal reimbursement.
Compared to national averages, Alaska's commercial payers consistently reimburse at higher rates. Aetna's mean rate in Alaska is $170.94, more than double its national mean of $79.86. The table and chart below present the full breakdown of payer-specific rates and percentiles for Alaska, highlighting the state's elevated reimbursement environment for this procedure.
Key Insights for Alaska
- Aetna is the highest paying payer in Alaska for CPT 51784, with a mean rate of $170.94.
- Medicare is the lowest paying payer, with a mean rate of $44.44, significantly below all commercial payers.
- All commercial payers in Alaska reimburse at rates well above their respective national averages, with Aetna's mean rate more than double its national benchmark.
Trek Health ingests and normalizes Transparency in Coverage data and payer policy updates to give provider organizations a clear view of how commercial reimbursement behaves across markets, payers, and services. Our platform transforms raw payer disclosures into structured intelligence that supports contract evaluation, payer negotiations, and service line strategy. By combining market benchmarks with ongoing policy visibility, Trek helps teams identify variability, risk, and opportunity in commercial reimbursement. The result is faster insight, stronger negotiating positions, and more informed financial decisions.